Article Text

other Versions

PDF
Toxic shock syndrome surveillance in UK children
  1. S Adalat1,
  2. T Dawson2,
  3. S J Hackett3,
  4. J E Clark4,
  5. In association with the British Paediatric Surveillance Unit
  1. 1Evelina Children's Hospital, London, UK
  2. 2Department of Paediatrics, Alexandra Hospital, Redditch, UK
  3. 3Department of Paediatrics, Heartlands Hospital, Birmingham, UK
  4. 4Great North Childrens Hospital, Newcastle upon Tyne, UK
  1. Correspondence to Dr Shazia Adalat, Evelina Childrens Hospital, St Thomas's Hospital, Westminster Bridge Road, London SE1 7EH, UK; s.adalat{at}nhs.net

Abstract

Background Toxic shock syndrome (TSS) is an acute toxin-mediated illness caused by toxin-producing strains of Staphylococcus aureus and Streptococcus pyogenes. There is no recent data regarding incidence, management and mortality of TSS in UK children.

Methods Consultants from paediatric and burns units in the UK and Ireland, reported cases of TSS seen between November 2008 and December 2009, via the British Paediatric Surveillance Unit. Respondents were sent questionnaires requesting detailed information about TSS cases. Established criteria were used to divide cases into staphylococcal or streptococcal TSS.

Results Forty-nine cases were identified overall; 29 cases of streptococcal TSS (18 confirmed and 11 probable) and 20 cases of staphylococcal TSS (15 confirmed and 5 probable). The incidence of TSS children in the UK & the Republic of Ireland was calculated to be 0.38 per 100 000 children. Children with staphylococcal TSS were older than those with streptococcal TSS (9.5 vs 3.8 years; p<0.003). Paediatric intensive care facilities were used for 78% of cases (invasive ventilatory support 69%; inotropic support 67%; haemofiltration 12%). Agents with antitoxin effects were underused; clindamycin 67%, intravenous immunoglobulin (IVIG) 20%, fresh frozen plasma 40%. There were eight deaths, all in the streptococcal group (28% of streptococcal cases)—none were given IVIG.

Conclusions Streptococcal TSS was as frequent as staphylococcal TSS, contrasting with previous literature. Children with streptococcal TSS had a higher mortality than those with staphylococcal TSS (28% vs 0%; p<0.05). Recommended immunomodulatory agents (IVIG and clindamycin) were underused. This study highlights the need for a guideline to improve management of TSS in children.

  • Infectious Diseases
  • Outcomes research
  • Paediatric Practice
  • Data Collection

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles